Search research articles
Contact Us
Filters
Showing results (181-190 of 216) with videos related to
Page
of 22
Sort By:
Brain Communications
|
September 8, 2022
Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with <sup>11</sup>C-BU99008 PET
Mohamed A Mohamed, Zhou Zeng, Marta Gennaro, et al.
The Lancet. Neurology
|
June 24, 2019
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Heather Wilson, George Dervenoulas, Gennaro Pagano, et al.
Journal of Medicinal Chemistry
|
December 8, 2010
Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands
Victor W Pike, Sabrina Taliani, Talakad G Lohith, et al.
Nature Communications
|
January 16, 2020
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi, Els F Halff, Thomas Whitehurst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2014
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET
Alessandro Colasanti, Qi Guo, Nils Muhlert, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancy
Sergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
Translational Psychiatry
|
March 2, 2025
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
Molecular Psychiatry
|
April 20, 2011
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans
E A Rabiner, J Beaver, A Makwana, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 12, 2018
Building a database for brain 18 kDa translocator protein imaged using [<sup>11</sup>C]PBR28 in healthy subjects
Soumen Paul, Evan Gallagher, Jeih-San Liow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 10, 2018
Disease-related patterns of in vivo pathology in Corticobasal syndrome
Flavia Niccolini, Heather Wilson, Stephanie Hirschbichler, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 216) with videos related to
Sort By:
Page
of 22
Brain Communications
|
September 8, 2022
Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with <sup>11</sup>C-BU99008 PET
Mohamed A Mohamed, Zhou Zeng, Marta Gennaro, et al.
The Lancet. Neurology
|
June 24, 2019
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Heather Wilson, George Dervenoulas, Gennaro Pagano, et al.
Journal of Medicinal Chemistry
|
December 8, 2010
Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands
Victor W Pike, Sabrina Taliani, Talakad G Lohith, et al.
Nature Communications
|
January 16, 2020
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi, Els F Halff, Thomas Whitehurst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2014
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET
Alessandro Colasanti, Qi Guo, Nils Muhlert, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 14, 2010
Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancy
Sergio Abanades, Jasper van der Aart, Julien A R Barletta, et al.
Translational Psychiatry
|
March 2, 2025
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
Molecular Psychiatry
|
April 20, 2011
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans
E A Rabiner, J Beaver, A Makwana, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 12, 2018
Building a database for brain 18 kDa translocator protein imaged using [<sup>11</sup>C]PBR28 in healthy subjects
Soumen Paul, Evan Gallagher, Jeih-San Liow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 10, 2018
Disease-related patterns of in vivo pathology in Corticobasal syndrome
Flavia Niccolini, Heather Wilson, Stephanie Hirschbichler, et al.
Page
of 22